{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:45:08Z","timestamp":1787751908438,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"DOI":"10.1186\/s13690-026-01916-0","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:43:54Z","timestamp":1776311034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systematic review and meta-analysis of cervico-vaginal high-risk human papillomavirus prevalence in India prior to nationwide human papillomavirus vaccination"],"prefix":"10.1186","volume":"84","author":[{"given":"Indira","family":"Adhikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishu","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Baussano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"1916_CR1","unstructured":"Ferlay JEM, Lam F, Leversanne M et al. Global Cancer Observatory: Cancer Today; India Fact Sheet Lyon, France: International Agency for Research on Cancer; 2024 [Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/356-india-fact-sheet.pdf"},{"issue":"12","key":"1916_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 M, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"issue":"7","key":"1916_CR3","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S2468-2667(21)00046-3","volume":"6","author":"M Bonjour","year":"2021","unstructured":"Bonjour M, Charvat H, Franco EL, et al. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 2021;6(7):e510\u201321.","journal-title":"Lancet Public Health"},{"key":"1916_CR4","unstructured":"Union Minister Dr. Jitendra Singh announces India\u2019s first indigenously developed vaccine, CERVAVAC for the prevention of cervical cancer [press release]. Delhi: Press Infromation Bureau (PIB)2022."},{"issue":"12","key":"1916_CR5","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S1470-2045(23)00535-1","volume":"24","author":"JT Schiller","year":"2023","unstructured":"Schiller JT, Kreimer AR. An HPV vaccine from India: broadening possibilities for cervical cancer control. Lancet Oncol. 2023;24(12):1288\u20139.","journal-title":"Lancet Oncol"},{"key":"1916_CR6","unstructured":"WHO. Framework for Monitoring the Implementation of the WHO Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem: World Health Organization. 2023 [27\/09\/2024]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/ncds\/ncd-surveillance\/cxca\/220121-bls21466-who-cp-accompany-doc_v01-web_.pdf?sfvrsn=2d2c811c_5&download=true"},{"issue":"7","key":"1916_CR7","doi-asserted-by":"publisher","first-page":"e1096","DOI":"10.1016\/S2214-109X(23)00193-6","volume":"11","author":"F Sayinzoga","year":"2023","unstructured":"Sayinzoga F, Tenet V, Heideman DAM, et al. Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys. Lancet Glob Health. 2023;11(7):e1096\u2013104.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"1916_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.7326\/M20-2849","volume":"173","author":"I Baussano","year":"2020","unstructured":"Baussano I, Tshomo U, Tenet V, et al. Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011\u20132012 and 2018: A Cross-sectional Study. Ann Intern Med. 2020;173(11):888\u201394.","journal-title":"Ann Intern Med"},{"key":"1916_CR9","unstructured":"Bruni L, Albero G, Serrano B et al. Human Papillomavirus and Related Diseases in India. Summary Report, 2019. 2019."},{"issue":"3","key":"1916_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/PGP.0b013e31816085ba","volume":"27","author":"N Bhatla","year":"2008","unstructured":"Bhatla N, Dar L, Rajkumar Patro A, et al. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Pathol. 2008;27(3):426\u201330.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"1916_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/ijgc-00009577-200801000-00011","volume":"18","author":"YP Bao","year":"2008","unstructured":"Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer. 2008;18(1):71\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"1916_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1916_CR13","doi-asserted-by":"crossref","unstructured":"Munn ZMS, Lisy K, Riitano D, Tufanaru C. Systematic reviews of prevalence and incidence: JBI; 2020. Available from: https:\/\/jbi.global\/critical-appraisal-tools","DOI":"10.46658\/JBIRM-17-05"},{"issue":"8","key":"1916_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","volume":"27","author":"M Arbyn","year":"2021","unstructured":"Arbyn M, Simon M, Peeters E, et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 2021;27(8):1083\u201395.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1916_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"CJ Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof J, Castle PE, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009;124(3):516\u201320.","journal-title":"Int J Cancer"},{"issue":"7","key":"1916_CR16","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247.","journal-title":"BMJ Open"},{"issue":"5","key":"1916_CR17","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10682-012-9555-5","volume":"26","author":"S Nakagawa","year":"2012","unstructured":"Nakagawa S, Santos ESA. Methodological issues and advances in biological meta-analysis. Evol Ecol. 2012;26(5):1253\u201374.","journal-title":"Evol Ecol"},{"issue":"1","key":"1916_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijgo.2014.10.025","volume":"129","author":"BT Sureshkumar","year":"2015","unstructured":"Sureshkumar BT, Shanmughapriya S, Das BC, Natarajaseenivasan K. A population-based study of the prevalence of HPV in three districts of Tamil Nadu, India. Int J Gynaecol Obstet. 2015;129(1):58\u201361.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"1916_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/jmv.22261","volume":"84","author":"S Hussain","year":"2012","unstructured":"Hussain S, Bharadwaj M, Nasare V, et al. Human papillomavirus infection among young adolescents in India: impact of vaccination. J Med Virol. 2012;84(2):298\u2013305.","journal-title":"J Med Virol"},{"issue":"5","key":"1916_CR20","first-page":"40","volume":"16","author":"A Parwez","year":"2022","unstructured":"Parwez A, Singh S, Kumar R, et al. Determination and evaluation of HR-HPV genotype in different communities of Bihar, India. Int J Health Sci (Qassim). 2022;16(5):40\u20138.","journal-title":"Int J Health Sci (Qassim)"},{"issue":"1","key":"1916_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40944-016-0045-5","volume":"14","author":"A Peedicayil","year":"2016","unstructured":"Peedicayil A, Abraham P, Prasad J, et al. Community Prevalence of Human Papillomavirus by Self-Collected Samples in South India. Indian J Gynecologic Oncol. 2016;14(1):16.","journal-title":"Indian J Gynecologic Oncol"},{"issue":"12","key":"1916_CR22","doi-asserted-by":"publisher","first-page":"e0244242","DOI":"10.1371\/journal.pone.0244242","volume":"15","author":"R Muwonge","year":"2020","unstructured":"Muwonge R, Basu P, Gheit T, et al. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. PLoS ONE. 2020;15(12):e0244242.","journal-title":"PLoS ONE"},{"key":"1916_CR23","doi-asserted-by":"crossref","unstructured":"Bhattacharya A, Chakraborty K, Saha P et al. Cervical cytology abnormalities and associated genotype patterns of high-risk HPV infection in women of Tripura, North-East India: A Hospital-Based Study. Am J Epidemiol. 2024","DOI":"10.1093\/aje\/kwae364"},{"issue":"2","key":"1916_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.31557\/APJCP.2024.25.2.653","volume":"25","author":"S Panta","year":"2024","unstructured":"Panta S, Rajaram S, Heda A, et al. Community Screening for High-Risk Human Papilloma Virus Infection using Self-Sampling and \u2018Point-Of-Care\u2019 Test. Asian Pac J Cancer Prev. 2024;25(2):653\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"1916_CR25","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.7314\/APJCP.2015.16.4.1519","volume":"16","author":"U Sarma","year":"2015","unstructured":"Sarma U, Mahanta J, Borkakoty B, Sarmah B. Distribution of human papilloma virus infections of uterine cervix among women of reproductive age\u2013a cross sectional hospital-based study from North East India. Asian Pac J Cancer Prev. 2015;16(4):1519\u201323.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"1916_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/0019-509X.27932","volume":"43","author":"R Aggarwal","year":"2006","unstructured":"Aggarwal R, Gupta S, Nijhawan R, et al. Prevalence of high\u2013risk human papillomavirus infections in women with benign cervical cytology: a hospital based study from North India. Indian J Cancer. 2006;43(3):110\u20136.","journal-title":"Indian J Cancer"},{"issue":"2","key":"1916_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ijgo.12859","volume":"146","author":"P Adsul","year":"2019","unstructured":"Adsul P, Srinivas V, Gowda S, et al. A community-based, cross-sectional study of hrHPV DNA self-sampling-based cervical cancer screening in rural Karnataka, India. Int J Gynaecol Obstet. 2019;146(2):170\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"1916_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejogrb.2004.11.025","volume":"121","author":"R Arora","year":"2005","unstructured":"Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol. 2005;121(1):104\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"1916_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1089\/gtmb.2011.0354","volume":"16","author":"A Asiaf","year":"2012","unstructured":"Asiaf A, Ahmad ST, Zargar MA, Mufti SM, Mir SH. Prevalence of human papillomavirus infection in a Kashmiri ethnic female population. Genet Test Mol Biomarkers. 2012;16(8):904\u20139.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1916_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canep.2018.03.005","volume":"54","author":"A Bhattacharya","year":"2018","unstructured":"Bhattacharya A, Sen S, Mandal P, et al. Prevalence and age-wise distribution of Human Papillomavirus type 16\/18 infections among hospital screened women of a peri-urban area in West Bengal: Impact of socio-demographic factors. Cancer Epidemiol. 2018;54:31\u20137.","journal-title":"Cancer Epidemiol"},{"key":"1916_CR31","doi-asserted-by":"crossref","unstructured":"Dakshinamurthy S, Racherla RG, Belagal P, Bharathi T, Sai Gopal DVR. Detection and Partial Molecular Characterization (E6\u2013E7 Region-Early Genes) and Prevalence of Human Papillomavirus (HPV) Causing Cervical Cancer in and Around Tirupati Region, Andhra Pradesh. Indian J Gynecologic Oncol. 2023;21(2).","DOI":"10.1007\/s40944-022-00702-4"},{"issue":"2","key":"1916_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canep.2009.12.016","volume":"34","author":"P Datta","year":"2010","unstructured":"Datta P, Bhatla N, Dar L, et al. Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol. 2010;34(2):157\u201361.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"1916_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PGP.0b013e3182399391","volume":"31","author":"S Dutta","year":"2012","unstructured":"Dutta S, Begum R, Mazumder Indra D, et al. Prevalence of human papillomavirus in women without cervical cancer: a population-based study in Eastern India. Int J Gynecol Pathol. 2012;31(2):178\u201383.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"1916_CR34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/sj.bjc.6602348","volume":"92","author":"S Franceschi","year":"2005","unstructured":"Franceschi S, Rajkumar R, Snijders PJ, et al. Papillomavirus infection in rural women in southern India. Br J Cancer. 2005;92(3):601\u20136.","journal-title":"Br J Cancer"},{"issue":"10","key":"1916_CR35","first-page":"Qc06","volume":"10","author":"A Garg","year":"2016","unstructured":"Garg A, Suri V, Nijhawan R, et al. Prevalence of Human Papilloma Virus Infection in Young Primiparous Women During Postpartum Period: Study from a Tertiary Care Center in Northern India. J Clin Diagn Res. 2016;10(10):Qc06\u20139.","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"1916_CR36","doi-asserted-by":"publisher","first-page":"e0219173","DOI":"10.1371\/journal.pone.0219173","volume":"14","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Shetty RS, Pattanshetty SM, et al. Human papilloma and other DNA virus infections of the cervix: A population based comparative study among tribal and general population in India. PLoS ONE. 2019;14(6):e0219173.","journal-title":"PLoS ONE"},{"issue":"4","key":"1916_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2303.2008.00611.x","volume":"20","author":"S Gupta","year":"2009","unstructured":"Gupta S, Sodhani P, Sharma A, et al. Prevalence of high-risk human papillomavirus type 16\/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Cytopathology. 2009;20(4):249\u201355.","journal-title":"Cytopathology"},{"issue":"1","key":"1916_CR38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11033-020-06082-2","volume":"48","author":"B Gupta","year":"2021","unstructured":"Gupta B, Sunnam LB, Kumar A, Parikipandla S. Prevalence of human papillomavirus 16 genotype in Anuppur district, Madhya Pradesh. Mol Biol Rep. 2021;48(1):503\u201311.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"1916_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/0970-9371.117684","volume":"30","author":"V Kashyap","year":"2013","unstructured":"Kashyap V, Hedau S. Value of high-risk human papillomavirus 16 deoxyribonucleic acid testing with cytological entities in peri and postmenopausal women. J Cytol. 2013;30(3):190\u20134.","journal-title":"J Cytol"},{"issue":"3","key":"1916_CR40","first-page":"25","volume":"5","author":"KS kaur Navneet","year":"2019","unstructured":"kaur Navneet KS. To Study the Prevalence of HPV Genome in HIV Positive Women in Comparison to HIV Negative Women in India. Annals Int Med Dent Res. 2019;5(3):25\u20137.","journal-title":"Annals Int Med Dent Res"},{"issue":"1","key":"1916_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1525-1438.2007.00827.x","volume":"17","author":"P Laikangbam","year":"2007","unstructured":"Laikangbam P, Sengupta S, Bhattacharya P, et al. A comparative profile of the prevalence and age distribution of human papillomavirus type 16\/18 infections among three states of India with focus on northeast India. Int J Gynecol Cancer. 2007;17(1):107\u201317.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"1916_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.4103\/ijcm.ijcm_800_22","volume":"49","author":"S Mittal","year":"2024","unstructured":"Mittal S, Kansal Y, Singh B, Gupta V. High-risk HPV Prevalence Estimates among Older Patients: Implications for Cervical Cancer Screening Programs. Indian J Community Med. 2024;49(4):599\u2013603.","journal-title":"Indian J Community Med"},{"issue":"1","key":"1916_CR43","first-page":"13","volume":"37","author":"S Pankaj","year":"2024","unstructured":"Pankaj S, Rani J, Kumari P, et al. Prevalence, risk factors and genotype distribution of human papillomavirus infection among women with and without invasive cervical cancer: Findings from a hospital-based study in Bihar, India. Natl Med J India. 2024;37(1):13\u20137.","journal-title":"Natl Med J India"},{"issue":"1","key":"1916_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12905-024-02967-7","volume":"24","author":"R Parvez","year":"2024","unstructured":"Parvez R, Vijayachari P, Thiruvengadam K, et al. A population based study on human papillomavirus infection and associated risk factors among women of the remote South Andaman Island, India. BMC Womens Health. 2024;24(1):139.","journal-title":"BMC Womens Health"},{"issue":"4","key":"1916_CR45","doi-asserted-by":"publisher","first-page":"e28715","DOI":"10.1002\/jmv.28715","volume":"95","author":"V Ramshankar","year":"2023","unstructured":"Ramshankar V, Ravindran S, Arun K, et al. Impact of HPV molecular testing with partial genotyping as a feasibility study in cervical cancer community screening program in South India. J Med Virol. 2023;95(4):e28715.","journal-title":"J Med Virol"},{"key":"1916_CR46","doi-asserted-by":"crossref","unstructured":"Sarkar K, Pal R, Bal B et al. Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis. 2011;11.","DOI":"10.1186\/1471-2334-11-72"},{"issue":"3","key":"1916_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13337-023-00838-7","volume":"34","author":"GK Sarvesan","year":"2023","unstructured":"Sarvesan GK, Parthasarathy K, Padhiar C. Genotypic characterization of HPV serotypes in cervical samples from Indian women: a multi centric study. Virusdisease. 2023;34(3):395\u2013401.","journal-title":"Virusdisease"},{"issue":"10","key":"1916_CR48","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/OLQ.0b013e318223be5f","volume":"38","author":"C Sauvaget","year":"2011","unstructured":"Sauvaget C, Nene BM, Jayant K, et al. Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women. Sex Transm Dis. 2011;38(10):902\u20136.","journal-title":"Sex Transm Dis"},{"key":"1916_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2334-5-116","volume":"5","author":"AP Sowjanya","year":"2005","unstructured":"Sowjanya AP, Jain M, Poli UR, et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis. 2005;5:116.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1916_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12038-012-9181-y","volume":"37","author":"S Srivastava","year":"2012","unstructured":"Srivastava S, Gupta S, Roy JK. High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. J Biosci. 2012;37(1):63\u201372.","journal-title":"J Biosci"},{"issue":"2","key":"1916_CR51","first-page":"61","volume":"3","author":"S Srivastava","year":"2014","unstructured":"Srivastava S, Shahi UP, Dibya A, Gupta S, Roy JK. Distribution of HPV Genotypes and Involvement of Risk Factors in Cervical Lesions and Invasive Cervical Cancer: A Study in an Indian Population. Int J Mol Cell Med. 2014;3(2):61\u201373.","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"1916_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40944-021-00496-x","volume":"19","author":"MJ Subramanian","year":"2021","unstructured":"Subramanian MJ, Rajaraman S, Vijayakumar VA, Community-Based. Study on Prevalence, Genotype Distribution and Persistence of High-Risk Human Papilloma Virus Infection of Uterine Cervix in Rural South India. Indian J Gynecologic Oncol. 2021;19(1):16.","journal-title":"Indian J Gynecologic Oncol"},{"issue":"8","key":"1916_CR53","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1002\/jmv.27015","volume":"93","author":"A Suresh","year":"2021","unstructured":"Suresh A, Suresh P, Biswas R, Rajanbabu A, Sreedhar S, Biswas L. Prevalence of high-risk HPV and its genotypes-Implications in the choice of prophylactic HPV vaccine. J Med Virol. 2021;93(8):5188\u201392.","journal-title":"J Med Virol"},{"issue":"3","key":"1916_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijgo.2012.06.019","volume":"119","author":"K Vinodhini","year":"2012","unstructured":"Vinodhini K, Shanmughapriya S, Sanmugham S, Senthikumar G, Das BC, Natarajaseenivasan K. Prevalence of high-risk HPV and associated risk factors in cases of cervical carcinoma in Tamil Nadu, India. Int J Gynaecol Obstet. 2012;119(3):253\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"1916_CR55","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ijgo.14428","volume":"162","author":"KS Vora","year":"2023","unstructured":"Vora KS, Saiyed S, Joshi R, Natesan S. Prevalence of high-risk HPV among marginalized urban women in India and its implications on vaccination: A cross sectional study. Int J Gynaecol Obstet. 2023;162(1):176\u201382.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"1916_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid2701.191364","volume":"27","author":"I Baussano","year":"2021","unstructured":"Baussano I, Sayinzoga F, Tshomo U, et al. Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan. Emerg Infect Dis. 2021;27(1):1\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"1916_CR57","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ijc.30092","volume":"139","author":"S Franceschi","year":"2016","unstructured":"Franceschi S, Chantal Umulisa M, Tshomo U, et al. Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda. Int J Cancer. 2016;139(3):518\u201326.","journal-title":"Int J Cancer"},{"issue":"1","key":"1916_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser Stat Soc. 2009;172(1):137\u201359.","journal-title":"J R Stat Soc Ser Stat Soc"},{"issue":"32 Pt A","key":"1916_CR59","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1016\/j.vaccine.2018.02.002","volume":"36","author":"S Franceschi","year":"2018","unstructured":"Franceschi S, Clifford GM, Baussano I. Options for design of real-world impact studies of single-dose vaccine schedules. Vaccine. 2018;36(32 Pt A):4816\u201322.","journal-title":"Vaccine"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-026-01916-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-026-01916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-026-01916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:02:27Z","timestamp":1779858147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13690-026-01916-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1186\/s13690-026-01916-0","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent for participation: Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient consent for publication: Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}